Avacta Group PLC signs first significant pharmaceutical licensing deal

(3:38)

AVACTA GROUP PLC - Investor Presentation

(1:3:46)

AVCT Stock Price Prediction News Today 12 April - Avacta Group Plc

(1:53)

Avacta firmly focused on first-in-human Affimer therapeutic trial

(8:21)

Avacta Group PLC boss sees a huge opportunity with new version of cancer treatment

(1:)

Avacta Group's Bach BioSciences deal 'an exciting step' - Capital Network analyst

(5:8)

AVACTA GROUP PLC - Review of the AVA6000 clinical trial’s Phase 1a data

(59:39)

AVACTA GROUP PLC - Post AGM Presentation and Investor Q\u0026A

(1:8:51)

BREAKOUT IS NEAR : AVACTA GROUP SHARE | AVACTA GROUP PLC SHARE

(1:59)

Avacta Group PLC Advancing Cancer Therapies And Diagnostics #stockmarket #stocks

(3:56)

AVCT Stock Price Prediction News Today 10 April - Avacta Group Plc

(1:33)

ADVFN - Avacta Group CEO interview

(10:18)

AVACTA GROUP PLC - Final Results

(1:3:57)

Avacta Group boss explains potential of its Affimer technology

(9:37)

AVACTA GROUP PLC - Final Results

(57:)

Executive interview – Avacta Group

(4:33)

Abbott Freestyle Libre 3 Review — A Discrete CGM For Diabetics

(4:14)

Bloomberg Turnaround: AstraZeneca

(24:7)

Make a Difference Working at AbbVie

(1:23)

Avacta Group CEO Alastair Smith confident of licensing deals this year

(7:10)

Avacta Group Plc making 'excellent progress' on lead programmes

(9:8)

Avacta Group boss talks through 'excellent' Affimer study results

(8:50)